Compare NTES & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTES | COR |
|---|---|---|
| Founded | 1997 | 2001 |
| Country | China | United States |
| Employees | 25382 | N/A |
| Industry | Computer Software: Prepackaged Software | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.7B | 68.5B |
| IPO Year | N/A | 2001 |
| Metric | NTES | COR |
|---|---|---|
| Price | $119.80 | $309.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $160.00 | ★ $390.62 |
| AVG Volume (30 Days) | 1.0M | ★ 1.4M |
| Earning Date | 05-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.61% | 0.77% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | N/A | ★ 11.27 |
| Revenue | N/A | ★ $321,332,819,000.00 |
| Revenue This Year | $9.57 | $8.89 |
| Revenue Next Year | $8.57 | $6.75 |
| P/E Ratio | $79.88 | ★ $27.07 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $106.06 | $244.82 |
| 52 Week High | $159.55 | $377.54 |
| Indicator | NTES | COR |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 63.14 |
| Support Level | $118.67 | $308.48 |
| Resistance Level | $120.05 | $312.18 |
| Average True Range (ATR) | 2.54 | 7.02 |
| MACD | -1.52 | -0.09 |
| Stochastic Oscillator | 6.55 | 79.20 |
Founded in the late 1990s as an internet portal, NetEase has evolved into China's second-largest online gaming company. Its early success was anchored by the massively multiplayer online role-playing game Fantasy Westward Journey, which laid the foundation for a durable franchise strategy. Over the past decade, the company has expanded its portfolio with successful titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which continue to maintain sizable and engaged player bases.In addition to its in-house development capabilities, NetEase partners with global IP holders such as Microsoft and Marvel to develop and publish titles based on established franchises, including World of Warcraft, Diablo Immortal, and Marvel Rivals, further strengthening its global presence.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.